• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成肽 ∆M3 对产超广谱β-内酰胺酶大肠杆菌分离株的膜活性研究。

Study of the Membrane Activity of the Synthetic Peptide ∆M3 Against Extended-Spectrum β-lactamase Escherichia coli Isolates.

机构信息

Chemistry Institute, Faculty of Exact and Natural Sciences, University of Antioquia, A.A. 1226, Medellin, 050010, Colombia.

Grupo de Investigación e Innovación Biomédica, Facultad de Ciencias Exactas y Aplicadas, Instituto Tecnológico Metropolitano, A.A. 54959, Medellín, 050010, Colombia.

出版信息

J Membr Biol. 2024 Apr;257(1-2):51-61. doi: 10.1007/s00232-024-00306-3. Epub 2024 Feb 5.

DOI:10.1007/s00232-024-00306-3
PMID:38315239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11006780/
Abstract

Escherichia coli is the most common microorganism causing nosocomial or community-acquired bacteremia, and extended-spectrum β-lactamase-producing Escherichia coli isolates are identified worldwide with increasing frequency. For this reason, it is necessary to evaluate potential new molecules like antimicrobial peptides. They are recognized for their biological potential which makes them promising candidates in the fight against infections. The goal of this research was to evaluate the potential of the synthetic peptide ΔM3 on several extended-spectrum β-lactamase producing E. coli isolates. The antimicrobial and cytotoxic activity of the peptide was spectrophotometrically determined. Additionally, the capacity of the peptide to interact with the bacterial membrane was monitored by fluorescence microscopy and infrared spectroscopy. The results demonstrated that the synthetic peptide is active against Escherichia coli isolates at concentrations similar to Meropenem. On the other hand, no cytotoxic effect was observed in HaCaT keratinocyte cells even at 10 times the minimal inhibitory concentration. Microscopy results showed a permeabilizing effect of the peptide on the bacteria. The infrared results showed that ΔM3 showed affinity for the lipids of the microorganism's membrane. The results suggest that the ∆M3 interacts with the negatively charged lipids from the E. coli by a disturbing effect on membrane. Finally, the secondary structure experiments of the peptide showed a random structure in solution that did not change during the interaction with the membranes.

摘要

大肠埃希菌是引起医院获得性或社区获得性菌血症最常见的微生物,产超广谱β-内酰胺酶的大肠埃希菌分离株在全球范围内的检出率越来越高。因此,有必要评估像抗菌肽这样的潜在新分子。它们的生物学潜力得到了认可,使它们成为抗感染的有前途的候选物。本研究的目的是评估合成肽 ΔM3 对几种产超广谱β-内酰胺酶的大肠埃希菌分离株的潜在作用。通过分光光度法测定了该肽的抗菌和细胞毒性活性。此外,通过荧光显微镜和红外光谱监测肽与细菌膜的相互作用能力。结果表明,该合成肽对大肠埃希菌分离株的活性与美罗培南相似。另一方面,即使在最小抑菌浓度的 10 倍时,也未观察到对 HaCaT 角质形成细胞的细胞毒性作用。显微镜结果显示该肽对细菌有渗透作用。红外结果表明,ΔM3 与微生物膜的脂质具有亲和力。结果表明,ΔM3 通过对膜的干扰作用与大肠埃希菌的带负电荷的脂质相互作用。最后,该肽的二级结构实验表明,在溶液中呈无规则结构,与膜相互作用时不会发生变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5529/11006780/0264a0dc22ee/232_2024_306_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5529/11006780/a3ed7529efe2/232_2024_306_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5529/11006780/35939edefb5f/232_2024_306_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5529/11006780/5dae775f2e26/232_2024_306_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5529/11006780/e189a3475693/232_2024_306_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5529/11006780/0264a0dc22ee/232_2024_306_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5529/11006780/a3ed7529efe2/232_2024_306_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5529/11006780/35939edefb5f/232_2024_306_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5529/11006780/5dae775f2e26/232_2024_306_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5529/11006780/e189a3475693/232_2024_306_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5529/11006780/0264a0dc22ee/232_2024_306_Fig5_HTML.jpg

相似文献

1
Study of the Membrane Activity of the Synthetic Peptide ∆M3 Against Extended-Spectrum β-lactamase Escherichia coli Isolates.合成肽 ∆M3 对产超广谱β-内酰胺酶大肠杆菌分离株的膜活性研究。
J Membr Biol. 2024 Apr;257(1-2):51-61. doi: 10.1007/s00232-024-00306-3. Epub 2024 Feb 5.
2
[Investigation of beta-lactamase genes and clonal relationship among the extended-spectrum beta-lactamase producing nosocomial Escherichia coli isolates].产超广谱β-内酰胺酶的医院内分离大肠埃希菌中β-内酰胺酶基因及克隆关系的研究
Mikrobiyol Bul. 2015 Jan;49(1):15-25. doi: 10.5578/mb.8437.
3
Community-Acquired Uropathogenic , Antimicrobial Susceptibility, and Extended-Spectrum Beta-Lactamase Detection.社区获得性尿路致病性、抗菌药物敏感性和超广谱β-内酰胺酶检测。
MEDICC Rev. 2022 May 16;24(2):20-25. doi: 10.37757/mr2022.v24.n2.2.
4
Prevalence of Cefotaxime-Resistant Escherichia coli Isolates from Healthy Cattle and Sheep in Northern Spain: Phenotypic and Genome-Based Characterization of Antimicrobial Susceptibility.西班牙北部健康牛和羊中产头孢噻肟耐药大肠杆菌的流行情况:基于表型和基因组对抗菌药物敏感性的特征描述。
Appl Environ Microbiol. 2020 Jul 20;86(15). doi: 10.1128/AEM.00742-20.
5
Activity of Cefotetan against ESBL-Producing Escherichia coli and Klebsiella pneumoniae Bloodstream Isolates from the MERINO Trial.美罗培南优化研究(MERINO)中头孢替坦对产 ESBL 大肠埃希菌和肺炎克雷伯菌血流分离株的活性。
Microbiol Spectr. 2021 Sep 3;9(1):e0022621. doi: 10.1128/Spectrum.00226-21. Epub 2021 Jul 7.
6
Increased community-acquired upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in children and the efficacy of flomoxef and cefmetazole.产超广谱β-内酰胺酶大肠埃希菌引起的儿童社区获得性上尿路感染增加及氟氧头孢和头孢美唑的疗效。
Clin Exp Nephrol. 2019 Nov;23(11):1306-1314. doi: 10.1007/s10157-019-01775-w. Epub 2019 Aug 19.
7
Phenotypic Characterization of Multidrug-resistant Escherichia Coli with Special Reference to Extended-spectrum-beta-lactamases and Metallo-beta-lactamases in a Tertiary Care Center.三级医疗中心耐多药大肠杆菌的表型特征,特别提及超广谱β-内酰胺酶和金属β-内酰胺酶
JNMA J Nepal Med Assoc. 2015 Apr-Jun;53(198):89-95.
8
Dissemination and characterisation of Escherichia coli producing extended-spectrum β-lactamases, AmpC β-lactamases and metallo-β-lactamases from livestock and poultry in Northeast India: A molecular surveillance approach.从印度东北部的家畜和家禽中传播和鉴定产生超广谱β-内酰胺酶、AmpC β-内酰胺酶和金属β-内酰胺酶的大肠杆菌:一种分子监测方法。
J Glob Antimicrob Resist. 2019 Jun;17:209-215. doi: 10.1016/j.jgar.2018.12.025. Epub 2019 Jan 8.
9
Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.质粒介导产AmpCβ-内酰胺酶的大肠杆菌在奥克兰社区引起尿路感染,可能对常用抗菌药物耐药。
N Z Med J. 2015 Mar 13;128(1410):50-9.
10
Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital.一家综合医院中产超广谱β-内酰胺酶大肠埃希菌和肺炎克雷伯菌的流行情况及抗菌药物敏感性
Ann Saudi Med. 2005 May-Jun;25(3):239-42. doi: 10.5144/0256-4947.2005.239.

本文引用的文献

1
Alterations of Autophagy Modify Lipids in Epidermal Keratinocytes.自噬的改变会影响表皮角质形成细胞中的脂质。
Clin Cosmet Investig Dermatol. 2023 Jun 20;16:1569-1581. doi: 10.2147/CCID.S410252. eCollection 2023.
2
Synthetic Cationic Lipopeptide Can Effectively Treat Mouse Mastitis Caused by .合成阳离子脂肽可有效治疗由……引起的小鼠乳腺炎。
Biomedicines. 2023 Apr 17;11(4):1188. doi: 10.3390/biomedicines11041188.
3
Cecropin D-derived synthetic peptides in the fight against cell filamentation and biofilm formation.来源于天蚕素D的合成肽对抗细胞丝状化和生物膜形成的研究
Front Microbiol. 2023 Jan 13;13:1045984. doi: 10.3389/fmicb.2022.1045984. eCollection 2022.
4
Understanding the Biophysical Interaction of LTX-315 with Tumoral Model Membranes.研究 LTX-315 与肿瘤模型细胞膜的生物物理相互作用。
Int J Mol Sci. 2022 Dec 29;24(1):581. doi: 10.3390/ijms24010581.
5
Biophysical Characterization of LTX-315 Anticancer Peptide Interactions with Model Membrane Platforms: Effect of Membrane Surface Charge.生物物理特性分析 LTX-315 抗癌肽与模型膜平台的相互作用:膜表面电荷的影响。
Int J Mol Sci. 2022 Sep 12;23(18):10558. doi: 10.3390/ijms231810558.
6
Antimicrobial peptides: On future antiprotozoal and anthelminthic applications.抗菌肽:未来在抗寄生虫和抗蠕虫方面的应用。
Acta Trop. 2022 Nov;235:106665. doi: 10.1016/j.actatropica.2022.106665. Epub 2022 Aug 24.
7
Comparison of the global prevalence and trend of human intestinal carriage of ESBL-producing between healthcare and community settings: a systematic review and meta-analysis.医疗保健机构与社区环境中产生超广谱β-内酰胺酶的人类肠道携带的全球患病率及趋势比较:一项系统评价和荟萃分析。
JAC Antimicrob Resist. 2022 Jun 2;4(3):dlac048. doi: 10.1093/jacamr/dlac048. eCollection 2022 Jun.
8
Antibiotics at the crossroads - Do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance?抗生素处于十字路口——我们是否有任何治疗替代方案来控制抗菌药物耐药性的出现和传播?
J Educ Health Promot. 2021 Nov 30;10:438. doi: 10.4103/jehp.jehp_557_21. eCollection 2021.
9
Antifungal Peptides and Proteins to Control Toxigenic Fungi and Mycotoxin Biosynthesis.抗真菌肽和蛋白质控制产毒真菌和真菌毒素生物合成。
Int J Mol Sci. 2021 Dec 9;22(24):13261. doi: 10.3390/ijms222413261.
10
Measures used to assess the burden of ESBL-producing infections in humans: a scoping review.用于评估产超广谱β-内酰胺酶感染对人类负担的措施:一项范围综述。
JAC Antimicrob Resist. 2021 Feb 14;3(1):dlaa104. doi: 10.1093/jacamr/dlaa104. eCollection 2021 Mar.